US10385087B1 - Xylose derivatives and process for preparation thereof - Google Patents

Xylose derivatives and process for preparation thereof Download PDF

Info

Publication number
US10385087B1
US10385087B1 US15/963,154 US201815963154A US10385087B1 US 10385087 B1 US10385087 B1 US 10385087B1 US 201815963154 A US201815963154 A US 201815963154A US 10385087 B1 US10385087 B1 US 10385087B1
Authority
US
United States
Prior art keywords
triol
pyran
tetrahydro
yloxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US15/963,154
Inventor
Kuo-Yuan Hwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Taipei University of Technology
Original Assignee
National Taipei University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Taipei University of Technology filed Critical National Taipei University of Technology
Priority to US15/963,154 priority Critical patent/US10385087B1/en
Assigned to NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY reassignment NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HWA, KUO-YUAN
Priority to EP19171251.2A priority patent/EP3560942A1/en
Priority to JP2019085750A priority patent/JP6759410B2/en
Application granted granted Critical
Publication of US10385087B1 publication Critical patent/US10385087B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/44—Palladium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention relates to a new method for synthesis of xylose derivatives and new xylose derivatives as prepared therefrom.
  • Green chemistry is defined as the environmentally friendly design of chemical products and processes. It is a philosophy of chemical research and engineering that encourages the development of products and processes that minimize the use and generation of hazardous substances. Relevant examples include reducing toxic waste, using renewable raw materials, enabling ambient-condition reactions to lower energy consumption, using smaller amounts of catalyst, and enabling high-percentage recovery of the catalyst, etc. Green chemistry seeks to reduce and prevent pollution at its source and applies to biochemistry, organic chemistry, inorganic chemistry, physical chemistry, analytical chemistry, and even carbohydrate chemistry. Most commonly, it focuses on industrial applications such as minimizing hazardous waste and maximizing efficiency.
  • a green chemistry method needs the following features: (1) use of non-toxic catalysts and solvents; and (2) use of renewable resources to synthesize chemical compounds.
  • saccharide chemistry has become well established in medical applications such as biological materials and drug syntheses. Saccharide drugs are used for the treatment of cancer, diabetes, AIDS, influenza, bacterial infections, and rheumatoid arthritis. Remarkable research has also been done on saccharide vaccines in recent years. However, most of the saccharide drugs originate from nature such as the polysaccharides and glycosides of plants, animals, and microorganisms.
  • Xylose is a sugar first isolated from wood, is classified as a monosaccharide of the aldopentose type. It is derived from hemicellulose, one of the main constituents of biomass. It was reported that the acid-catalysed degradation of hemicellulose gives furfiral. In addition, since xylose does not contain calories, it can be used as diet food. Xylose and xylose derivatives may be applied in various fields. Particularly, xylose and its derivatives may be applied in green chemistry industry.
  • the present invention provides a new method for synthesis of a xylose derivative in the aqueous phase in the presence of organometallic catalysts.
  • xylose can be modified to provide various functional groups, which may affect the organism and/or enable its application in biological materials.
  • the present invention provides a xylose derivative having the general formula I:
  • the xylose derivative is one selected from the group consisting of the following:
  • the present invention provides a method of synthesis of the xylose derivatives according to the present invention.
  • the method comprises the steps of:
  • the halogen atom is an iodine atom.
  • the water-soluble ligand is recycled.
  • the palladium catalyst is recycled.
  • the palladium catalyst is PdCl 2 (NH 3 ) 2
  • the water-soluble ligand is a cationic 2,2′-bipyridyl ligand.
  • a cationic 2,2′-bipyridyl ligand is dissolved in water to form a solution A; and PdCl 2 (NH 3 ) 2 is dissolved in water to form a solution B; and adding the solution A to the solution B to generate a turbid solution that eventually cleared to obtain a water-soluble palladium catalyst.
  • the Suzuki cross-couplings reaction is carried out at a temperature no higher than 100° C.
  • FIG. 1A shows the 1 H NMR spectrum of the starting material 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks for the hydrogen atoms in the tetrahydrofuran and hydroxyl moieties in the range of ⁇ ⁇ 3.00-5.50 ppm, wherein the peak at 2.0 ppm disappears rather than the peaks corresponding to the benzene ring.
  • FIG. 1B shows the 13 C NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the solvent peak at ⁇ 43.5 ppm and the hydroxyl group at the C1 position of xylose appears at ⁇ 2.0 ppm.
  • FIG. 2A shows the 1 H NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 2B shows the enlargement of the 1 H NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 2C shows the 13 C NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 2D shows the enlargement of 13 C NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 3A shows the 1 H NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 3B shows the enlargement of the 1 H NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 3C shows the 13 C NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 4A shows the 1 H NMR spectrum of 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 4B shows the 13 C NMR spectrum of 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 5A shows the 1 H NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. Peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 5B shows the enlargement of the 1 H NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 5C shows the 13 C NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 6A shows the 1 H NMR spectrum of 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 6B shows the 13 C NMR spectrum of 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 7A shows the 1 H NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 7B shows the enlargement of the 1 H NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 7C shows the 13 C NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 8A shows the 1 H NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 8B shows the enlargement of the 1 H NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 8C shows the 13 C NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 9A shows the 1 H NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 9B shows the enlargement of the 1 H NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 9C shows the 13 C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 10A shows the 1 H NMR spectrum of 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 10B shows the enlargement of the 1 H NMR spectrum of 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 10C shows the 13 C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 11A shows the 1 H NMR spectrum of 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIG. 11B shows the 13 C NMR spectrum of 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • a halogen atom refers to one atom selected from one group in the periodic table consisting of five chemically related elements: fluorine (F), chlorine (Cl), bromine (Br), iodine (I), and astatine (At).
  • the present invention provides a method for synthesis of a xylose derivative in the aqueous phase in the presence of a water-soluble palladium catalyst, which provides a friendly and economical green chemistry method for synthesis of xylose derivatives.
  • the water-soluble ligand is a cationic 2,2-bipyridyl ligand, which may be synthesis according to the scheme below (Xue et al., Carbohydrate Research 344:1646-1653, 2009):
  • 4,4′-Dicarboxyl-2,2′-bipyridine (6.12 g) was dissolved in 115 mL of MeOH (aq) and 15 mL of H 2 SO 4(aq) . The solution was refluxed at ⁇ 90-100° C. for 24 hours after which the reaction was quenched with 300 mL of DDW. NaOH (aq) was added until the pH reached ⁇ 8.0. The organic layer was extracted using dichloromethane (2 ⁇ 50 mL) and dried with MgSO 4 . It was then filtered and concentrated in a vacuum evaporator to yield the solid product (5.9 g, 87%). The compound was identified using 1 H NMR spectroscopy.
  • 4,4′-Bis(hydroxymethyl)-2,2′-bipyridine (4.46 g) was dissolved in 30 mL of HBr (48%) and 10 mL of concentrated sulfuric acid. The solution was then refluxed for 6 hours at 110° C. When the solution changed from light yellow to golden, the heat was removed and 100 mL of DDW was added to quench the reaction. The pH of the solution was adjusted to 7.0 using NaOH(aq), which caused the precipitation of a pink compound. The precipitate was collected via filtration, washed with DDW, and dried under vacuum. The liquid portion was extracted with ethyl acetate (2 ⁇ 50 mL), dried with MgSO 4 , filtered, and concentrated in a vacuum evaporator. The desired product (4.39 g, 88%) was obtained and identified via 1 H NMR spectroscopy.
  • 4,4′-Bis(bromomethyl)-2,2′-bipyridine (0.5 g) was dissolved in dichloromethane and 20 mL of trimethylamine (50%) was added. The mixture was left to react for 24 hours at room temperature. A freeze dryer was used for 2 days to remove any water and obtain the desired product.
  • the palladium catalyst is PdCl 2 (NH 3 ) 2 , which is also known as Pd(NH 3 ) 2 Cl 2 .
  • the water-soluble palladium catalyst may be prepared according to the scheme below:
  • the cationic 2,2′-bipyridyl ligand (0.2 mmol) was dissolved in 5 mL of water in a round bottom flask to form solution A.
  • PdCl 2 (NH 3 ) 2 (0.2 mmol) was dissolved 10 mL of water in a separate round bottom flask to form solution B.
  • Solution A was slowly added to solution B under ultrasonic vibration to generate a turbid solution that eventually cleared.
  • 5 mL of water was used to fully transfer solution B into solution A until the solution was completely clear.
  • the resultant water-soluble palladium catalyst has a concentration of 0.2 mmol/20 mL, i.e., 0.01 mmol/mL. This solution was diluted to prepare aqueous solutions of palladium catalyst with concentrations of 0.001 and 0.0001 mmol/mL.
  • a sealable tube equipped with a magnetic stirrer bar was charged with the starting material (1 mmol), arylboronic acid (1.5 mmol), K 2 CO 3 (2 mmol), and H 2 O (2 mL).
  • the addition of TBAB (1 mmol) was required.
  • the tube was sealed under air using a Teflon-coated screw cap.
  • the reaction vessel was then placed in an oil bath at 100° C. or no higher than 100° C. for 24 hours. After cooling the reaction mixture to room temperature, the aqueous solution was extracted with ethyl acetate, the organic phase was dried over MgSO 4 , and the solvent was removed under vacuum. Column chromatography on silica gel afforded the desired product.
  • the Suzuki cross-couplings reaction is carried out at a temperature no higher than 100° C.
  • a sealable tube equipped with a magnetic stirrer bar was charged with the starting material (1 mmol), 4-chlorophenylboronic acid (1.5 mmol), K 2 CO 3 (2 mmol), and H 2 O (2 mL).
  • the addition of TBAB (1 mmol) was required.
  • the tube was sealed under air using a Teflon-coated screw cap.
  • the reaction vessel was then placed in an oil bath at 100° C. for 24 hours. After cooling the reaction mixture to room temperature, the aqueous solution was extracted with ethyl acetate, the organic phase was dried over MgSO 4 , and the solvent was removed under vacuum.
  • any protective groups commonly used in the art may be used in this present invention.
  • acyl protective groups commonly used in carbohydrate chemistry alkyl ethers used in ether protection to identify and analyze the polysaccharides, cyclic acetals or cycloketals in acetal ketone protection, protective groups for amino moieties such as N-acetyl and phthalyl and other protective groups.
  • the xylose derivative is one selected from the group consisting of the following:
  • FIG. 1A shows the 1 H NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks for the hydrogen atoms in the tetrahydrofuran and hydroxyl moieties in the range of ⁇ ⁇ 3.00-5.50 ppm.
  • FIG. 1A shows the 1 H NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks for the hydrogen atoms in the tetrahydrofuran and hydroxyl moieties in the range of ⁇ ⁇ 3.00-5.50 ppm.
  • FIG. 1A shows the 1 H NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks for the hydrogen atoms in the tetrahydrofuran and hydroxyl moieties in the range of ⁇ ⁇ 3.00-5.
  • FIG. 1B shows the 13 C NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, wherein the solvent peak appears at ⁇ 43.5 ppm and the hydroxyl group at the Cl position of xylose appears at ⁇ 2.0 ppm.
  • the peak at ⁇ 2.0 ppm disappears in FIG. 1A , rather than the peaks corresponding to the benzene ring. Therefore, it was confirmed that the expected product was obtained.
  • Example 1 The starting material as obtained in Example 1 was used to synthesize xylose derivatives through a Suzuki cross-coupling reaction with a palladium catalyst in a water solution, the scheme of which is given below:
  • FIGS. 2A and 2B show the 1 H NMR spectra of 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIGS. 2C and 2D show the 13 C NMR spectra of 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 3A and 3B show the 1 H NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 3C shows the 13 C NMR spectra of 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 4A and 4B show the 1 H NMR and 13 C NMR spectrum of 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, respectively.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 5A and 5B show the 1 H NMR spectra of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 5C show the 13 C NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 7A and 7B show the 1 H NMR spectra of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 7C show the 13 C NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 8A and 8B show the 1 H NMR spectra of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 8C shows the 13 C NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 9A and 9B show the 1 H NMR spectra of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 9C shows the 13 C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 10A and 10B show the 1 H NMR spectra of 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
  • FIG. 10C shows the 13 C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
  • FIGS. 11A and 11B show the 1 H NMR and 13 C NMR spectra of 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, respectively.
  • the peaks in the range of ⁇ ⁇ 3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)

Abstract

Disclosure of the present invention relates to a method for synthesis of a xylose derivative, which comprises protecting a xylose with a protective group, followed by incorporating to a halogen atom as a leaving group; removing the protective groups and using water-soluble ligands to carry out a Suzuki cross-couplings reaction with a palladium catalyst in a water solution. Ten new xylose derivatives as obtained by the method are also provided.

Description

FIELD OF THE INVENTION
The present invention relates to a new method for synthesis of xylose derivatives and new xylose derivatives as prepared therefrom.
BACKGROUND OF THE INVENTION
Green chemistry is defined as the environmentally friendly design of chemical products and processes. It is a philosophy of chemical research and engineering that encourages the development of products and processes that minimize the use and generation of hazardous substances. Relevant examples include reducing toxic waste, using renewable raw materials, enabling ambient-condition reactions to lower energy consumption, using smaller amounts of catalyst, and enabling high-percentage recovery of the catalyst, etc. Green chemistry seeks to reduce and prevent pollution at its source and applies to biochemistry, organic chemistry, inorganic chemistry, physical chemistry, analytical chemistry, and even carbohydrate chemistry. Most commonly, it focuses on industrial applications such as minimizing hazardous waste and maximizing efficiency.
Recently, the development of water-soluble homogeneous catalysts contributes to economical green chemistry. Since water-soluble catalysts are easy to separate from the organic phase, they avoid the use of organic solvents and are cost effective and environmentally friendly. Normally, a green chemistry method needs the following features: (1) use of non-toxic catalysts and solvents; and (2) use of renewable resources to synthesize chemical compounds.
In recent years, saccharide chemistry has become well established in medical applications such as biological materials and drug syntheses. Saccharide drugs are used for the treatment of cancer, diabetes, AIDS, influenza, bacterial infections, and rheumatoid arthritis. Remarkable research has also been done on saccharide vaccines in recent years. However, most of the saccharide drugs originate from nature such as the polysaccharides and glycosides of plants, animals, and microorganisms.
Xylose is a sugar first isolated from wood, is classified as a monosaccharide of the aldopentose type. It is derived from hemicellulose, one of the main constituents of biomass. It was reported that the acid-catalysed degradation of hemicellulose gives furfiral. In addition, since xylose does not contain calories, it can be used as diet food. Xylose and xylose derivatives may be applied in various fields. Particularly, xylose and its derivatives may be applied in green chemistry industry.
However, it is desirable to develop an economical and efficient method to obtain various xylose derivatives through green chemistry method.
SUMMARY OF THE INVENTION
Accordingly, the present invention provides a new method for synthesis of a xylose derivative in the aqueous phase in the presence of organometallic catalysts. Through the method, it is easy to modify xylose; to obtain new xylose derivatives from nature. Since the catalyst can be recycled and water is used as the solvent, the reaction is environmentally friendly and economical. Xylose can be modified to provide various functional groups, which may affect the organism and/or enable its application in biological materials.
In one aspect, the present invention provides a xylose derivative having the general formula I:
Figure US10385087-20190820-C00001
formula I,
wherein the m for (R)m is an integer from 1 to 4; R is CH3, OCH3, or a halogen atom.
In the embodiment of the invention, the xylose derivative is one selected from the group consisting of the following:
Figure US10385087-20190820-C00002
  • 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 1);
Figure US10385087-20190820-C00003
  • 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 2);
Figure US10385087-20190820-C00004
  • 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 3);
Figure US10385087-20190820-C00005
  • 2-(2′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 4);
Figure US10385087-20190820-C00006
  • 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 5);
Figure US10385087-20190820-C00007
  • 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 6);
Figure US10385087-20190820-C00008
  • 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 7);
Figure US10385087-20190820-C00009
  • 2-(3′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 8);
Figure US10385087-20190820-C00010
  • 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 9); and
Figure US10385087-20190820-C00011
  • 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 10).
In another aspect, the present invention provides a method of synthesis of the xylose derivatives according to the present invention. The method comprises the steps of:
protecting a xylose with a protective group, followed by incorporating to a halogen atom as a leaving group;
removing the protective group and using a water-soluble ligand to carry out Suzuki cross-couplings reaction with a palladium catalyst in a water solution to synthesize the derivative.
In one example of the invention, the halogen atom is an iodine atom.
In one example of the invention, the water-soluble ligand is recycled.
In one example of the invention, the palladium catalyst is recycled.
In one example of the invention, the palladium catalyst is PdCl2(NH3)2, and the water-soluble ligand is a cationic 2,2′-bipyridyl ligand.
In one example of the invention, a cationic 2,2′-bipyridyl ligand is dissolved in water to form a solution A; and PdCl2(NH3)2 is dissolved in water to form a solution B; and adding the solution A to the solution B to generate a turbid solution that eventually cleared to obtain a water-soluble palladium catalyst.
In one example of the invention, the Suzuki cross-couplings reaction is carried out at a temperature no higher than 100° C.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawing.
In the drawings:
FIG. 1A shows the 1H NMR spectrum of the starting material 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks for the hydrogen atoms in the tetrahydrofuran and hydroxyl moieties in the range of δ˜3.00-5.50 ppm, wherein the peak at 2.0 ppm disappears rather than the peaks corresponding to the benzene ring.
FIG. 1B shows the 13C NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the solvent peak at ∂ 43.5 ppm and the hydroxyl group at the C1 position of xylose appears at δ2.0 ppm.
FIG. 2A shows the 1H NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 2B shows the enlargement of the 1H NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 2C shows the 13C NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 2D shows the enlargement of 13C NMR spectrum of 2-(4′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 3A shows the 1H NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 3B shows the enlargement of the 1H NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 3C shows the 13C NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 4A shows the 1H NMR spectrum of 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 4B shows the 13C NMR spectrum of 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 5A shows the 1H NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. Peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 5B shows the enlargement of the 1H NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 5C shows the 13C NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 6A shows the 1H NMR spectrum of 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 6B shows the 13C NMR spectrum of 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 7A shows the 1H NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 7B shows the enlargement of the 1H NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 7C shows the 13C NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 8A shows the 1H NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 8B shows the enlargement of the 1H NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 8C shows the 13C NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 9A shows the 1H NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 9B shows the enlargement of the 1H NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 9C shows the 13C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 10A shows the 1H NMR spectrum of 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 10B shows the enlargement of the 1H NMR spectrum of 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol.
FIG. 10C shows the 13C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
FIG. 11A shows the 1H NMR spectrum of 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks in the range of δ˜3.00-5.50 ppm correlating with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties.
FIG. 11B shows the 13C NMR spectrum of 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol.
 DESCRIPTION OF THE INVENTION
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by a person skilled in the art to which this invention belongs.
As used herein, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a sample” includes a plurality of such samples and equivalents thereof known to those skilled in the art.
As used herein, the term “a halogen atom” refers to one atom selected from one group in the periodic table consisting of five chemically related elements: fluorine (F), chlorine (Cl), bromine (Br), iodine (I), and astatine (At).
The present invention provides a method for synthesis of a xylose derivative in the aqueous phase in the presence of a water-soluble palladium catalyst, which provides a friendly and economical green chemistry method for synthesis of xylose derivatives.
The technologies and materials involved in the present invention are illustrated below.
Solvent Purification
On a distillation apparatus under a nitrogen atmosphere, magnesium sulfate was added to dichloromethane in the distilling flask and the temperature was set at ˜50° C. The distillate was collected in a flask containing dried molecular sieves.
Free-of-Water and Air Process
If the reactions are sensitive to water and air, all experimental processes including reaction, extraction, drying, concentration and column chromatography must be carried out in the absence of air under nitrogen conditions. Therefore, the solvents and chemicals must be free of water and air before use and the liquids must be transferred using syringes and flex needles (Teflon). The solution is concentrated using a rotary vacuum concentrator and a vacuum motor.
Reaction Scheme
According to the invention, the scheme of the total reactions in the method for synthesis of a xylose derivative is given below:
Figure US10385087-20190820-C00012
Acetylation Reaction
In one example of the invention, the scheme of acetylation reaction is given below:
Figure US10385087-20190820-C00013
A solution of 0.75 g of xylose (5 mmol), 2.84 mL (30 mmol) of acetic anhydride, and 2.04 g (30 mmol) of imidazole in 700 mL of dichloromethane was placed in an ice bath for 30 min and then stirred for 12 hours. The reaction was then quenched by the addition of methanol and stirred in ice for 30 min. The mixture was diluted with dichloromethane, adjusted to a neutral pH using HCl, and extracted with Et2O. The usual work-up and column chromatography afforded acetylated xylose (1.50 g, 94%) as a white solid.
Phenol Derivation Reaction
In one example of the invention, the scheme of phenol derivation reaction is given below (Lee et al., CARBOHYDRATE CHEMISTRY. 20(6): 503-506, 2001):
Figure US10385087-20190820-C00014
A solution of 1.59 g (5 mmol) of acetylated xylose, 1.29 g (7.5 mmol) of 4-bromophenol, 0.7 mL (5 mmol) of TEA, and 0.87 mL (12.5 mmol) in 30 mL of dichloromethane under a nitrogen atmosphere was stirred for 24 hours to convert the 4-bromophenol to 4-iodophenol. The mixture was diluted with 20 mL of saturated aqueous NaHCO3(aq) and extracted with Et2O (30 mL×3). The usual work-up and column chromatography afforded the product (1.29 g, 54%) as a white solid.
Deacetylation Reaction
In one example of the invention, the scheme of deacetylation reaction is given below (Will et al., J. Phys CHEM. B, 103:8067, 1999):
Figure US10385087-20190820-C00015
A solution of 0.478 g (1 mmol) of starting material and 0.33 g (6 mmol) of sodium methoxide in 20 mL of methanol under a constant pressure of air was stirred for 8 hours. The mixture was adjusted to a neutral pH by the addition of HCl and then extracted with Et2O (30 mL×3). The usual work-up and column chromatography afforded the product (0.32 g, 91%) as a white solid.
Synthesis of Cationic 2,2-Bipyridyl Ligand
In the embodiment of the invention, the water-soluble ligand is a cationic 2,2-bipyridyl ligand, which may be synthesis according to the scheme below (Xue et al., Carbohydrate Research 344:1646-1653, 2009):
Figure US10385087-20190820-C00016
The following ligands may be used in the present invention:
  • 4,4′-dicarboxyl-2,2′-bipyridine;
  • 4,4′-dimethoxycarbonyl-2,2′-bipyridine;
  • 4,4′-bis(hydroxymethyl)-2,2′-bipyridine;
  • 4,4′-bis(bromomethyl)-2,2′-bipyridine; or
  • cationic 2,2′-bipyridine ligand.
The syntheses of the above mentioned ligands are given below.
(1) Synthesis of 4,4′-dicarboxyl-2,2′-bipyridine
The scheme of the synthesis of 4,4′-dicarboxyl-2,2′-bipyridine is given below:
Figure US10385087-20190820-C00017
4,4′-Dimethyl-2,2′-bipyridine (5 g) was dissolved in 125 mL of H2SO4 (98%). K2Cr2O7 was added and the temperature was maintained between ˜70-80° C. The reaction was quenched when the solution changed from yellow to black. A yellow solid was obtained after filtration and concentration. This yellow solid was dissolved in 170 mL of HNO3(aq) (50%) and refluxed for 4 hours. The solution was then diluted to 1 L, filtered, and washed with water and acetone. After concentrating the solution, the product was obtained (6.12 g, 93%) as a white solid and identified using 1H NMR spectroscopy.
(2) Synthesis of 4,4′-dimethoxycarbonyl-2,2′-bipyridine
The scheme of synthesis of 4,4′-dimethoxycarbonyl-2,2′-bipyridine is given below:
Figure US10385087-20190820-C00018
4,4′-Dicarboxyl-2,2′-bipyridine (6.12 g) was dissolved in 115 mL of MeOH(aq) and 15 mL of H2SO4(aq). The solution was refluxed at ˜90-100° C. for 24 hours after which the reaction was quenched with 300 mL of DDW. NaOH(aq) was added until the pH reached ˜8.0. The organic layer was extracted using dichloromethane (2×50 mL) and dried with MgSO4. It was then filtered and concentrated in a vacuum evaporator to yield the solid product (5.9 g, 87%). The compound was identified using 1H NMR spectroscopy.
(3) Synthesis of 4,4′-bis(hydroxymethyl)-2,2′-bipyridine
The scheme of the synthesis of 4,4′-bis(hydroxymethyl)-2,2′-bipyridine is given below:
Figure US10385087-20190820-C00019
4,4′-Dimethoxycarbonyl-2,2′-bipyridine (5.9 g) was dissolved in pure EtOH to which sodium borohydride (12 g) was added. The mixture was refluxed for 3 hours at ˜90-100° C. After cooling to room temperature, saturated NH4Cl(aq) was added followed by 300 mL of DDW. The solution was then extracted using ethyl acetate (5×250 mL), dried with MgSO4, filtered and then concentrated in a vacuum evaporator to obtain the desired solid (4.46 g, 95%). The product was identified using 1H NMR spectroscopy.
(4) Synthesis of 4,4′-bis(bromomethyl)-2,2′-bipyridine
The scheme of the synthesis of 4,4′-bis(bromomethyl)-2,2′-bipyridine is given below:
Figure US10385087-20190820-C00020
4,4′-Bis(hydroxymethyl)-2,2′-bipyridine (4.46 g) was dissolved in 30 mL of HBr (48%) and 10 mL of concentrated sulfuric acid. The solution was then refluxed for 6 hours at 110° C. When the solution changed from light yellow to golden, the heat was removed and 100 mL of DDW was added to quench the reaction. The pH of the solution was adjusted to 7.0 using NaOH(aq), which caused the precipitation of a pink compound. The precipitate was collected via filtration, washed with DDW, and dried under vacuum. The liquid portion was extracted with ethyl acetate (2×50 mL), dried with MgSO4, filtered, and concentrated in a vacuum evaporator. The desired product (4.39 g, 88%) was obtained and identified via 1H NMR spectroscopy.
(5) Synthesis of cationic 2,2′-bipyridine Ligand
The Scheme of the synthesis of cationic 2,2′-bipyridine ligand is given below:
Figure US10385087-20190820-C00021
4,4′-Bis(bromomethyl)-2,2′-bipyridine (0.5 g) was dissolved in dichloromethane and 20 mL of trimethylamine (50%) was added. The mixture was left to react for 24 hours at room temperature. A freeze dryer was used for 2 days to remove any water and obtain the desired product.
Preparation of the Water-Soluble Palladium Catalyst
In one embodiment of the invention, the palladium catalyst is PdCl2(NH3)2, which is also known as Pd(NH3)2Cl2. The water-soluble palladium catalyst may be prepared according to the scheme below:
Figure US10385087-20190820-C00022
The cationic 2,2′-bipyridyl ligand (0.2 mmol) was dissolved in 5 mL of water in a round bottom flask to form solution A. PdCl2(NH3)2 (0.2 mmol) was dissolved 10 mL of water in a separate round bottom flask to form solution B. Solution A was slowly added to solution B under ultrasonic vibration to generate a turbid solution that eventually cleared. Finally, 5 mL of water was used to fully transfer solution B into solution A until the solution was completely clear. The resultant water-soluble palladium catalyst has a concentration of 0.2 mmol/20 mL, i.e., 0.01 mmol/mL. This solution was diluted to prepare aqueous solutions of palladium catalyst with concentrations of 0.001 and 0.0001 mmol/mL.
Suzuki Cross-Coupling Reaction
The scheme of Suzuki cross-coupling reaction is given below (Wu et al., Tetrahedron Letters. 47: 9267-927, 2006):
Figure US10385087-20190820-C00023
A sealable tube equipped with a magnetic stirrer bar was charged with the starting material (1 mmol), arylboronic acid (1.5 mmol), K2CO3 (2 mmol), and H2O (2 mL). In the case of styrene, the addition of TBAB (1 mmol) was required. After the addition of the Pd(NH3)2Cl2/L aqueous solution, the tube was sealed under air using a Teflon-coated screw cap. The reaction vessel was then placed in an oil bath at 100° C. or no higher than 100° C. for 24 hours. After cooling the reaction mixture to room temperature, the aqueous solution was extracted with ethyl acetate, the organic phase was dried over MgSO4, and the solvent was removed under vacuum. Column chromatography on silica gel afforded the desired product.
In one example of the invention, the Suzuki cross-couplings reaction is carried out at a temperature no higher than 100° C.
Recycling of Water-Soluble Palladium Catalyst
The scheme of the recycling of water-soluble palladium catalyst is given below (Wu et al., Tetrahedron Letters. 47: 9267-9270, 2006):
Figure US10385087-20190820-C00024
A sealable tube equipped with a magnetic stirrer bar was charged with the starting material (1 mmol), 4-chlorophenylboronic acid (1.5 mmol), K2CO3 (2 mmol), and H2O (2 mL). In the case of styrene, the addition of TBAB (1 mmol) was required. After the addition of the Pd(NH3)2Cl2/L aqueous solution, the tube was sealed under air using a Teflon-coated screw cap. The reaction vessel was then placed in an oil bath at 100° C. for 24 hours. After cooling the reaction mixture to room temperature, the aqueous solution was extracted with ethyl acetate, the organic phase was dried over MgSO4, and the solvent was removed under vacuum. Column chromatography on silica gel afforded the desired product. After the reaction, the aqueous reaction mixture was washed with ethyl acetate three times with vigorous stirring and the organic product was isolated from the combined organic phase according to a previously described procedure. The residual aqueous solution was then charged with 4-chlorophenylboronic acid and K2CO3 for the next reaction; in the case of styrene, the addition of TBAB for the first run was required.
Protective Groups
Any protective groups commonly used in the art may be used in this present invention. For instance, acyl protective groups commonly used in carbohydrate chemistry, alkyl ethers used in ether protection to identify and analyze the polysaccharides, cyclic acetals or cycloketals in acetal ketone protection, protective groups for amino moieties such as N-acetyl and phthalyl and other protective groups. Some common protective groups are listed below:
(1) Esters:
Figure US10385087-20190820-C00025
(2) Ethers:
Figure US10385087-20190820-C00026
(3) Acetals (Ketals):
Figure US10385087-20190820-C00027
(4) Aminos:
Figure US10385087-20190820-C00028
According to the invention, new xylose derivatives have been synthesized, which have the general formula I
Figure US10385087-20190820-C00029
formula I,
wherein the m for (R)m is an integer from 1 to 4; R is CH3, OCH3, or a halogen atom.
In the examples of the invention, the xylose derivative is one selected from the group consisting of the following:
Figure US10385087-20190820-C00030
  • 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 1);
Figure US10385087-20190820-C00031
  • 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 2);
Figure US10385087-20190820-C00032
  • 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 3);
Figure US10385087-20190820-C00033
  • 2-(2′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 4);
Figure US10385087-20190820-C00034
  • 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 5);
Figure US10385087-20190820-C00035
  • 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 6);
Figure US10385087-20190820-C00036
  • 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 7);
Figure US10385087-20190820-C00037
  • 2-(3′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 8);
Figure US10385087-20190820-C00038
  • 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 9); and
Figure US10385087-20190820-C00039
  • 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 10).
The present invention is further illustrated by the following examples, which are provided for the purpose of demonstration rather than limitation
EXAMPLES Example 1 Preparation of Starting Material
For synthesis of xylose derivatives, 2-(4-iodophenoxy) tetrahydro-2H-pyran-3,4,5-triol as shown below is used as a starting material:
Figure US10385087-20190820-C00040
The scheme of the total reactions of the starting material is given below:
Figure US10385087-20190820-C00041
The crude product was purified by column chromatography on silica gel and gave the product as a white power in a 45.9% yield. FIG. 1A shows the 1H NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, which features the peaks for the hydrogen atoms in the tetrahydrofuran and hydroxyl moieties in the range of δ˜3.00-5.50 ppm. FIG. 1B shows the 13C NMR spectrum of 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, wherein the solvent peak appears at δ43.5 ppm and the hydroxyl group at the Cl position of xylose appears at δ2.0 ppm. However, the peak at δ2.0 ppm disappears in FIG. 1A, rather than the peaks corresponding to the benzene ring. Therefore, it was confirmed that the expected product was obtained.
1H NMR (400 MHz, CD6SO): δ7.59 (d, J=8.8 Hz, 2H), 6.84 (d, J=8.8 Hz, 2H). 13C NMR (50 MHz, CD6SO): δ160.37, 141.89, 122.97, 104.79, 86.72, 80.27, 76.93, 73.24, 69.62. Mass Calcd for C11H13IO4: 336.08.
Preparation Examples for Syntheses of Xylose Derivatives
The starting material as obtained in Example 1 was used to synthesize xylose derivatives through a Suzuki cross-coupling reaction with a palladium catalyst in a water solution, the scheme of which is given below:
Figure US10385087-20190820-C00042
Ar—B(OH)2
The 10 xylose derivatives were synthesized and the purification and characterization thereof were given in the following examples. The results of the catalysis of xylose and arylboronic acids (Ar—B(OH)2) are given in Table 1.
TABLE 1
Results of the catalysis of xylose and arylboronic acids
Yield Weight
Compound No. Ar—B(OH)2 Structure of Product (%) (g)
Compound 1
Figure US10385087-20190820-C00043
Figure US10385087-20190820-C00044
 		71.4 0.121
Compound 2
Figure US10385087-20190820-C00045
Figure US10385087-20190820-C00046
 		54.5 0.086
Compound 3
Figure US10385087-20190820-C00047
Figure US10385087-20190820-C00048
 		78.3 0.131
Compound 4
Figure US10385087-20190820-C00049
Figure US10385087-20190820-C00050
 		51.8 0.082
Compound 5
Figure US10385087-20190820-C00051
Figure US10385087-20190820-C00052
 		55.3 0.093
Compound 6
Figure US10385087-20190820-C00053
Figure US10385087-20190820-C00054
 		60.8 0.101
Compound 7
Figure US10385087-20190820-C00055
Figure US10385087-20190820-C00056
 		87.5 0.138
Compound 8
Figure US10385087-20190820-C00057
Figure US10385087-20190820-C00058
 		92.0 0.139
Compound 9
Figure US10385087-20190820-C00059
Figure US10385087-20190820-C00060
 		77.2 0.13
Compound 10
Figure US10385087-20190820-C00061
Figure US10385087-20190820-C00062
 		98.0 0.162
Example 2 2-(4′-Chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 1)
Figure US10385087-20190820-C00063
The crude product was purified by column chromatography on silica gel to yield the purified product as a white powder in a 79.2% yield. FIGS. 2A and 2B show the 1H NMR spectra of 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. FIGS. 2C and 2D show the 13C NMR spectra of 2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, the hydrogen peak shifts from δ7.71 to 7.59 ppm. As shown in FIGS. 2A-2D, it is confirmed that the desired product was obtained.
1H NMR (200 MHz, CD6SO): δ7.64 (d, J=8.8 Hz, 2H), 7.59 (d, J=8 Hz, 2H), 7.46 (d, J=8.6, 2H), 7.08 (d, J=8.8 Hz, 2H). 13C NMR (50 MHz, CD6SO): δ156.89, 138.4, 132.39, 131.55, 128.86, 127.86, 127.52, 116.73, 100.86, 76.3, 72.97, 69.26, 65.61. Mass Calcd for C17H18O5: 302.12.
Example 3 2-(4′-Methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 2)
Figure US10385087-20190820-C00064
The crude product was purified by column chromatography on silica gel and gave the product as a white powder in a 54.5% yield. FIGS. 3A and 3B show the 1H NMR spectrum of 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. FIG. 3C shows the 13C NMR spectra of 2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy) tetrahydro-2H-pyran-3,4,5-triol, the hydrogen resonance shifts from δ7.71 to 7.55 ppm. As shown in FIGS. 3A-3C, it is confirmed that the desired product was obtained
1H NMR (200 MHz, CD6SO): δ7.55 (d, J=8.6 Hz, 2H), 7.49 (d, J=8.0 Hz, 2H), 7.23 (d, J=7.8 Hz, 2H), 7.06 (d, J=8.8 Hz, 2H), 2.32 (s, 3H). 13C NMR (50 MHz, CD6SO): δ156.45, 136.77, 135.96, 133.79, 129.25, 127.25, 125.99, 116.70, 101.01, 76.37, 69.30, 65.63, 20.53. Mass Calcd for C18H20O5: 316.13.
Example 4 2-(4′-Methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 3)
Figure US10385087-20190820-C00065
The crude product was purified by column chromatography on silica gel to obtain the product as a white powder in a 78.6% yield. FIGS. 4A and 4B show the 1H NMR and 13C NMR spectrum of 2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol, respectively. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, the chemical shift of the hydrogen atoms shifts from δ7.71 to 7.54 ppm. As shown in FIGS. 4A and 4B, it is confirmed that the desired product was obtained.
1H NMR (200 MHz, CD6SO): δ7.54 (d, J=4.0 Hz, 2H), 7.47 (d, J=8 Hz, 2H), 3.69 (s, 3H. 13C NMR (50 MHz, CD6SO): δ158.59, 156.16, 133.64, 127.25, 127.03, 116.72, 114.23, 101.04, 76.39, 73.03, 69.33, 65.64, 55.10. Mass Calcd for C18H20O6: 316.13.
Example 5 2-(2′-Methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 4)
Figure US10385087-20190820-C00066
The crude product was purified by column chromatography on silica gel to give the product as a white powder in a 51.8% yield. FIGS. 5A and 5B show the 1H NMR spectra of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. FIG. 5C show the 13C NMR spectrum of 2-(2′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, the resonance of the hydrogen atom shifted from δ7.71 to 7.25 ppm. As shown in FIGS. 5A-5C, it is confirmed that the desired product was obtained.
1H NMR (400 MHz, CD6SO): δ7.25 (d, J=7.28 Hz, 3H), 7.23 (t, J=7.4 Hz, 2H), 7.16 (d, J=4.48 Hz, 2H), 7.06 (d, J=4.48 Hz. 2H), 2.22 (s, 3H). 13C NMR (100 MHz, CD6SO): δ156.66, 141.34, 135.36, 135.22, 130.76, 130.44, 130.01, 127.52, 126.38, 116.46, 101.45, 76.95, 73.58, 69.87, 66.20, 20.71. Mass Calcd for C18H20O5: 316.13.
Example 6 2-(2′-Chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 5)
Figure US10385087-20190820-C00067
The crude product was purified by column chromatography on silica gel to give the product in a 59.3% yield as a white powder. As shown in FIGS. 6A and 6B providing the 1H NMR and 13C NMR spectra of 2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, respectively. The peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol), the resonance for the hydrogen atom shifted from δ7.71 to 7.39 ppm. A shown in FIGS. 6A and 6B, it is confirmed that the desired product was obtained
1H NMR (400 MHz, CD6SO): δ7.53 (d, 6.8 Hz, 1H), 7.39 (d, J=4.8 Hz, 2H), 7.37 (d, J=4.4 Hz, 1H), 7.35 (t, 6.8 Hz, 2H), 7.08 (d, J=8.8 MHz, 2H). 13C NMR (100 MHz, CD6SO): δ156.24, 138.87, 131.78, 130.94, 130.85, 129.81, 129.27, 128.34, 126.94, 115.44, 100.37, 75.92, 72.55, 72.55, 68. Mass Calcd for C17H17ClO5: 336.13.
Example 7 2-(2′-Methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 6)
Figure US10385087-20190820-C00068
The crude product was purified by column chromatography on silica gel to give the product as a white powder in a 60.8% yield. FIGS. 7A and 7B show the 1H NMR spectra of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. FIG. 7C show the 13C NMR spectrum of 2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy) tetrahydro-2H-pyran-3,4,5-triol, the resonance for the hydrogen atom shifts from δ7.71 to 7.39 ppm. As shown in FIGS. 7A-7C, it is confirmed that the desired product was obtained.
1H NMR (400 MHz, CD6SO): δ7.39 (d, 6.84 Hz, 2H), 7.32 (t, 5.24 Hz, 1H), 7.25 (d, 7.32 Hz, 1H), 7.09 (d, 6.16 Hz, 1H), 7.04 (d, 7.04 Hz, 1H), 7.00 (d, 5.96 Hz, 2H). 13C NMR (100 MHz, CD6SO): δ159.19, 156.34, 140.70, 133.25, 129.35, 127.22, 118.10, 116.18, 111.92, 111.32, 100.46, 75.90, 72.54, 68.83, 65.16, 54.54. Mass Calcd for C18H20O6: 332.13
Example 8 2-(3′-Methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 7)
Figure US10385087-20190820-C00069
The crude product was purified by column chromatography on silica gel to give the product as a white powder in an 87.5% yield. FIGS. 8A and 8B show the 1H NMR spectra of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. FIG. 8C shows the 13C NMR spectrum of 2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, the resonance for the hydrogen shifts from δ7.71 to 7.57 ppm. As shown in FIGS. 8A-8C, it is confirmed that the desired product was obtained.
1H NMR (400 MHz, CD6SO): δ 7.57 (d, 11.6 Hz, 2H), 7.41 (s, 1H), 7.30 (t, 6.4 Hz, 1H), 7.12 (d, 8H, 1H), 7.05 (d, 2.8 Hz, 2H), 2.49 (s, 3H). 13C NMR (100 MHz, CD6SO): δ159.19, 139.16, 137.39, 133.51, 128.19, 127.8, 126.41, 122.87, 116.20, 100.49, 75.90, 72.55, 68.84, 65.17, 20.56. Mass Calcd for C18H20O5: 316.12
Example 9 2-(3′-Methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 8)
Figure US10385087-20190820-C00070
The crude product was purified by column chromatography on silica gel to give the product as a white powder in a 92.0% yield. FIGS. 9A and 9B show the 1H NMR spectra of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol. FIG. 9C shows the 13C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, the resonance for the hydrogen atom shifts from δ7.71 to 7.59 ppm. As shown in FIGS. 9A-9C, it is confirmed that the desired product was obtained.
1H NMR (400 MHz, CD6SO): δ7.59 (d, J=3.6 Hz, 2H), 7.34 (t, J=8.0 Hz, 1H), 7.17 (d, J=8.8 Hz, 1H), 7.12 (s, 1H), 7.07 (D, J=8.8 Hz, 2H), 6.88 (d, J=8.4, 1H), 3.75 (s, 3H). 13C NMR (100 MHz, CD6SO): δ159.18, 156.34, 140.70, 133.25, 129.34, 127.21, 118.09, 116.18, 111.91, 111.30, 100.46, 75.89, 72.53, 68.83, 65.16, 54.54. Mass Calcd for C18H20O6: 332.13
Example 10 2-(3′-Chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 9)
Figure US10385087-20190820-C00071
The crude product was purified by column chromatography on silica gel to give the product as a white powder in a 77.2% yield. FIGS. 10A and 10B show the 1H NMR spectra of 2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol. FIG. 10C shows the 13C NMR spectrum of 2-(3′-methoxybiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy) tetrahydro-2H-pyran-3,4,5-triol, the resonance for the hydrogen atom shifts from δ7.71 to 7.63 ppm. As shown in FIGS. 10A-10C, it is confirmed that the desired product was obtained.
1H NMR (400 MHz, CD6SO): δ7.66 (s, J=8.0 Hz, 1H), 7.63 (d, J=8.0 Hz, 2H), 7.59 (d, J=9.8 Hz, 1H), 7.45 (t, J=8.0 Hz 1H), 7.35 (d, J=2 Hz, 1H), 7.10 (d, J=11.6 Hz, 2H). 13C NMR (100 MHz, CD6SO): δ156.23, 138.86, 131.77, 130.93, 130.84, 129.80, 129.26, 128.31, 126.92, 115.43, 110.36, 75.91, 72.54, 68.86, 65.19. Mass Calcd for C17H17ClO5: 336.08.
Example 11 2-(3′,5′-Dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 10)
Figure US10385087-20190820-C00072
The crude product was purified by column chromatography on silica gel to give the product as a white powder in a 98.0% yield. FIGS. 11A and 11B show the 1H NMR and 13C NMR spectra of 2-(3′,5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol, respectively. In the spectra, the peaks in the range of δ˜3.00-5.50 ppm correlate with the hydrogen atoms of the hydroxyl and tetrahydrofuran moieties. Since there is iodine in the starting material, i.e., 2-(4-iodophenoxy)tetrahydro-2H-pyran-3,4,5-triol, the resonance for the hydrogen atom shifts from δ7.71 to 7.07 ppm. As shown in FIGS. 11A and 11B, it is confirmed that the desired product was obtained.
1H NMR (400 MHz, CD6SO): δ7.5 6 (d, J=8.8 Hz, 2H), 7.21 (s, 2H), 7.07 (d, J=8.8 Hz, 2H), 6.95 (s, 1H), 2.32 (s, 6H). 13C NMR (100 MHz, CD6SO): δ156.12, 139.14, 137.21, 133.62, 127.74, 127.60, 123.60, 116.14, 110.49, 75.89, 72.54, 68.83, 65.17, 20.47. Mass Calcd for C19H22O5: 330.15.

Claims (2)

I claim:
1. A xylose derivative having the general formula I:
Figure US10385087-20190820-C00073
wherein the m for (R)m is an integer from 1 to 4; R is CH3, OCH3, or a halogen atom.
2. The xylose derivative of claim 1, which is one selected from the group consisting of the following:
Figure US10385087-20190820-C00074
2-(4′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 1);
Figure US10385087-20190820-C00075
2-(4′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 2);
Figure US10385087-20190820-C00076
2-(4′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 3);
Figure US10385087-20190820-C00077
2-(2′-methylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 4);
Figure US10385087-20190820-C00078
2-(2′-chlorobiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 5);
Figure US10385087-20190820-C00079
2-(2′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 6);
Figure US10385087-20190820-C00080
2-(3′-methylbiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 7);
Figure US10385087-20190820-C00081
2-(3′-methoxybiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 8);
Figure US10385087-20190820-C00082
2-(3′-chlorobiphenyl-4-yloxy) tetrahydro-2H-pyran-3,4,5-triol (Compound 9); and
Figure US10385087-20190820-C00083
2-(3′, 5′-dimethylbiphenyl-4-yloxy)tetrahydro-2H-pyran-3,4,5-triol (Compound 10).
US15/963,154 2018-04-26 2018-04-26 Xylose derivatives and process for preparation thereof Active US10385087B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US15/963,154 US10385087B1 (en) 2018-04-26 2018-04-26 Xylose derivatives and process for preparation thereof
EP19171251.2A EP3560942A1 (en) 2018-04-26 2019-04-26 Xylose derivatives and process for preparation thereof
JP2019085750A JP6759410B2 (en) 2018-04-26 2019-04-26 Xylose derivative and its production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/963,154 US10385087B1 (en) 2018-04-26 2018-04-26 Xylose derivatives and process for preparation thereof

Publications (1)

Publication Number Publication Date
US10385087B1 true US10385087B1 (en) 2019-08-20

Family

ID=66290239

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/963,154 Active US10385087B1 (en) 2018-04-26 2018-04-26 Xylose derivatives and process for preparation thereof

Country Status (3)

Country Link
US (1) US10385087B1 (en)
EP (1) EP3560942A1 (en)
JP (1) JP6759410B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111423478A (en) * 2020-04-16 2020-07-17 山东大学 A kind of xylose containing propargyl and its synthesis method
WO2021222702A1 (en) * 2020-05-01 2021-11-04 Flagship Pioneering Innovations V, Inc. Crystalline forms, compositions containing them, and methods of their use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025143777A1 (en) * 2023-12-27 2025-07-03 다임바이오 주식회사 Arabinose derivative compound, and composition comprising same for preventing or treating degenerative brain diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019509315A (en) * 2016-03-23 2019-04-04 フィンブリオン セラピューティックス， インコーポレイテッドＦｉｍｂｒｉｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． A mannose-derived antagonist of FimH useful for the treatment of disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Fritz et al., The Journal of Biological Chemistry, 1994, vol. 269, No. 1, pp. 300-307. (Year: 1994). *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111423478A (en) * 2020-04-16 2020-07-17 山东大学 A kind of xylose containing propargyl and its synthesis method
WO2021222702A1 (en) * 2020-05-01 2021-11-04 Flagship Pioneering Innovations V, Inc. Crystalline forms, compositions containing them, and methods of their use

Also Published As

Publication number Publication date
JP6759410B2 (en) 2020-09-23
JP2019194188A (en) 2019-11-07
EP3560942A1 (en) 2019-10-30

Similar Documents

Publication Publication Date Title
US9670174B2 (en) Mono- and dialkyl ethers of furan-2,5-dimethanol and (tetra-hydrofuran-2,5-diyl)dimethanol and amphiphilic derivatives thereof
Yang et al. Visible-light-promoted intramolecular C–H amination in aqueous solution: synthesis of carbazoles
US10385087B1 (en) Xylose derivatives and process for preparation thereof
CN116178336B (en) A method and application of synthesizing N-aryl ketimine by acid-catalyzed ketal method
Mohammadi-Aghdam et al. One-pot synthesis of highly regioselective β-azido alcohols catalyzed by Brønsted acidic ionic liquids
TW201945382A (en) Xylose derivatives and process for preparation thereof
KR100367986B1 (en) Optically active cyanobutantriol derivatives and process for preparing same
CN111318303B (en) Phenolate and application thereof
Alrubaie et al. Synthesis of novel polymer quaternary ammonium salt derived from glucose as a phase transfer catalyst
Azizi et al. Selective Deprotection of N-Tosyl Alkoxyamines Using Bistrifluoromethane Sulfonimide: Formation of Oxime Ethers
CN109265385B (en) Synthesis process of chiral catalyst
CN109053390B (en) Preparation method of 25, 27-diisopropoxy-26, 28-dihydroxy calix [4] arene
CN115260192B (en) A kind of nitrogen-containing condensed ring compound and its synthesis method
EP4353774B1 (en) Low-temperature organocatalyzed depolymerization of poly(ethylene terephthalate)
CN119143580B (en) A method for preparing 1,2-bis(4′-hydroxyphenyl)ethane
CN117946039B (en) A chiral synthesis process for an empagliflozin intermediate
CN113200860B (en) Preparation method of SGLT2 inhibitor intermediate
JP5636692B2 (en) Method for producing 5-hydroxy-1,3-dioxane and method for producing branched glycerol trimer using 5-hydroxy-1,3-dioxane obtained by the method as a raw material
CN114989115B (en) Improved synthesis of alpha- (nitromethyl) -2-furanmethanol and method for maintaining catalyst activity in the process
RU2755123C1 (en) (6r,8r,10s,12r,13ar)-5-methyl-3,6,7,8,9,10,11,12,13,13а-decahydro-1н-2,6: 6а,10:8,12-trimethanocyclonone[c]-azocine production method
CN113493385B (en) Method for synthesizing butenafine hydrochloride
Porzelle et al. Rapid access to in situ generated (R)-and (S)-2-furyloxirane and associated regioselective nucleophilic ring-opening studies
Chen et al. Utilizing a Mild and Effective Catalyst, Alum (KAl (SO4) 2⋅ 12H2O), for Carbohydrate Protection
CN108484484A (en) The preparation method of 2- oxygen-ethyl nipecotate
CN113387778A (en) Meta-alkenyl substituted aryl alkyl ether and preparation method and application thereof

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 4